Xenetic Biosciences, Inc.
XBIO
$3.28
$0.196.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.52% | 19.05% | 13.30% | -2.94% | 5.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.52% | 19.05% | 13.30% | -2.94% | 5.63% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 23.52% | 19.05% | 13.30% | -2.94% | 5.63% |
| SG&A Expenses | -15.49% | -19.64% | -22.59% | -24.31% | -6.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.57% | -13.33% | -10.38% | -24.13% | -11.66% |
| Operating Income | 38.27% | 32.58% | 24.09% | 34.80% | 20.35% |
| Income Before Tax | 39.10% | 32.31% | 22.59% | 34.35% | 17.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 39.10% | 32.31% | 22.59% | 34.35% | 17.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.10% | 32.31% | 22.59% | 34.35% | 17.99% |
| EBIT | 38.27% | 32.58% | 24.09% | 34.80% | 20.35% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 47.80% | 36.62% | 22.68% | 34.51% | 18.38% |
| Normalized Basic EPS | 47.80% | 36.63% | 22.68% | 34.51% | 18.38% |
| EPS Diluted | 47.80% | 36.62% | 22.68% | 34.51% | 18.40% |
| Normalized Diluted EPS | 47.80% | 36.63% | 22.68% | 34.51% | 18.38% |
| Average Basic Shares Outstanding | 22.52% | 10.40% | 0.11% | 0.25% | 0.49% |
| Average Diluted Shares Outstanding | 22.52% | 10.40% | 0.11% | 0.25% | 0.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |